ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/sPrrFCW7akI/fda-backs-roches-gazyva-in-first-line-follicular-lymphoma-idINKBN1DG2NV
By Mai Nguyen DANANG, Vietnam (Reuters) - Discord emerged between Japan and Canada over progress on the Trans Pacific Partnership (TPP) trade deal... ...http://www.sify.com/finance/japan-hails-progress-in-tpp-trade-talks-but-discord-raises-doubts-news-policy-rljqHAcijabee.html
GlaxoSmithKline has poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head as new Chief Executive... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/RXaksqnyWz4/gsk-grabs-roche-veteran-and-calico-scientist-barron-as-new-rd-head-idINKBN1D81YO
(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/r9fNMXRoctE/fda-approves-roche-drugs-for-rare-types-of-blood-lung-cancers-idINKBN1D62A4
By Cyril Altmeyer and Victoria Bryan PARIS/BERLIN (Reuters) - Shares in Air France-KLM, Europe's second-biggest airline, retreated on Friday as... ...http://www.sify.com/technology/air-france-klm-shares-slump-as-costs-take-shine-off-profits-news-news-rldmxSdaggigc.html
Roche is a Emerging company as a IVR...